Previous Article | Next Article 
Journal of Virology, March 2008, p. 2594-2597, Vol. 82, No. 5
0022-538X/08/$08.00+0 doi:10.1128/JVI.02039-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.
R-Peptide Cleavage Potentiates Fusion-Controlling Isomerization of the Intersubunit Disulfide in Moloney Murine Leukemia Virus Env
Robin Löving,
Kejun Li,
Michael Wallin,
Mathilda Sjöberg, and
Henrik Garoff*
Department of Biosciences and Nutrition, Karolinska Institute, S-141 57 Huddinge, Sweden
Received 14 September 2007/
Accepted 12 December 2007

ABSTRACT
Fusion of the membrane of the Moloney murine leukemia virus
(Mo-MLV) Env protein is facilitated by cleavage of the R peptide
from the cytoplasmic tail of its TM subunit, but the mechanism
for this effect has remained obscure. The fusion is also controlled
by the isomerization of the intersubunit disulfide of the Env
SU-TM complex. In the present study, we used several R-peptide-cleavage-inhibited
virus mutants to show that the R peptide suppresses the isomerization
reaction in both in vitro and in vivo assays. Thus, the R peptide
affects early steps in the activation pathway of murine leukemia
virus Env.

TEXT
During maturation of the Moloney murine leukemia virus (Mo-MLV),
the viral protease cleaves a 16-residue-long peptide, the R
peptide, from the cytoplasmic tail of the TM subunit of the
membrane fusion protein Env (
5,
6,
17). The cleavage potentiates
the receptor-induced fusion activation in Env, but the mechanism
for this effect has remained obscure (
7,
8,
15,
16,
18). Similar
regulation has been observed in other gammaretroviruses and
in the Mason-Pfizer monkey betaretrovirus (
2,
3). Recently,
it was shown that the activation of MLV fusion is also controlled
by receptor-induced isomerization of the intersubunit disulfide
of the Env SU-TM subunit complex (
14,
19). Here, we studied
whether R-peptide cleavage facilitates the isomerization.
R-peptide cleavage site mutants, shown to inhibit cleavage in earlier studies, were created at the P1 (L649V, L649R, and L649I) and P1' (V650I) positions by PCR mutagenesis, using Mo-MLV proviral DNA (4, 8, 16, 18). Corresponding particles were produced and labeled with 50 µCi/ml [35S]Cys in calcium phosphate precipitate-transfected HEK 293T cells. Analysis by reducing sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of sedimentation-purified viruses that had been lysed in buffer containing 50 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 2 mM EDTA and immunoprecipitated with anti-MLV polyclonal antibody (pAb) (HE863; Viromed Biosafety Laboratories) showed that the mutant Env's, with the exception of V650I, incorporated with wild-type (wt) efficiency and were significantly inhibited in R-peptide cleavage, i.e., in cleavage of the Pr15E form of TM into the p15E form (Table 1). Incorporation of Env-V650I was reduced to 63%, and the R peptide was cleaved as in the wt. The infectivities of the mutants were analyzed in XC cells by using MLV p12 monoclonal antibody (Ab) 548 (B. W. Chesebro, Rocky Mountain Laboratories). Cell binding was augmented by centrifugation of the virus-cell sample at 850 x g for 1 h at 4°C in the presence of 8 µg/ml polybrene. The infectivities of the mutants were found to correlate with the biochemical findings (Table 1). This was also the case with their fusion efficiencies, which were tested in an XC cell-to-cell fusion-from-without assay (19). Thus, all mutants but V650I were inhibited in R-peptide cleavage and membrane fusion. Notably, the cleavage inhibition was only partial, and the L649V mutant contained a significant fraction (about 30%) of R-peptide-cleaved SU-p15E complexes. To differentiate between the alkylated isomerization-arrested SU-Pr15E and SU-p15E complexes (see below), we introduced an anti-R-peptide Ab (K. B. Andersen, The Danish University of Pharmaceutical Sciences). This precipitated only Pr15E from lysed samples of the wt and mutants and SU-Pr15E complexes from samples that were lysed in the presence of N-ethylmaleimide (NEM), which blocked the lysis-induced isomerization by modifying the active thiol in SU (Fig. 1) (13).
Isomerization of the intersubunit disulfide is mediated by the
removal of suppressing Ca
2+ ion(s) from Env and can therefore
be triggered in vitro by subjecting the virus to Ca
2+ depletion
(
19). Furthermore, an alkaline pH decreases the triggering threshold
of the reaction by increasing the ionization of the isomerization-active
CXXC-thiol in SU (
9). Therefore, the effect of the R peptide
on isomerization was studied by incubating wt and mutant viruses
in Ca
2+-free TN buffer (14 mM Tris, 12 mM HEPES, 150 mM NaCl)
(pH 8.0) for 0 to 5 h at 37°C. After the incubation, NEM
(20 mM) was added, the samples were lysed, and the viral proteins
were immunoisolated with MLV pAb for isomerization analysis
by SDS-PAGE at nonreducing conditions. NEM prevented lysis-induced
isomerization and thus facilitated the measurement of the incubation-induced
isomerization. The latter was measured by monitoring the release
of subunits from covalently linked SU-TM complexes. As controls,
we used samples that were incubated with NEM. The analyses showed
that the kinetics of total Env isomerization was significantly
slower in the cleavage-inhibited mutants L649R and L649I than
in the wt and the cleavage-competent mutant V650I (Fig.
2A).
The decrease was less evident in the less-cleavage-inhibited
mutant L649V but was confirmed by quantification (Fig.
2B).
To avoid the problem of partial cleavage, we measured the levels
of isomerization separately for the SU-Pr15E and SU-p15E complexes
by quantifying Pr15E and p15E, which were released from the
corresponding covalently linked SU-TM complexes. The ratios
of the SU-p15E to SU-Pr15E complexes in the original nonincubated
samples were assumed to correspond to those of p15E to Pr15E
in the fully isomerized samples incubated for 5 h (Fig.
2A,
lanes 4, 8, 12, 16, and 20). The signal levels facilitated reliable
quantification of SU-p15E isomerization in wt, L649V, and V650I
and of SU-Pr15E isomerization in L649V, L649R, and L649I. The
quantifications showed that the SU-p15E complexes of the wt
and the mutants isomerized with mutually similar kinetics (Fig.
2C, column groups 1, 2, and 6). The SU-Pr15E complexes of the
different preparations also isomerized with mutually similar
kinetics but at a significantly slower rate than that of the
SU-p15E complexes (Fig.
2C, column groups 3 to 5). Thus, after
1 h of incubation, almost all of the SU-p15E complexes but less
than half of the SU-Pr15E complexes had isomerized. We concluded
that the R peptide suppresses the Ca
2+ depletion-triggered isomerization.
Receptor-mediated triggering of the isomerization reaction in
Env with uncleaved R peptide was studied by following the efficiency
by which Env was converted into a CXXC-thiol alkylatable intermediate.
After receptor binding and the removal of Ca
2+, Env obtains
an open conformation, which exposes the CXXC-thiol for modification
(
19,
20). Thus, if Env is activated in the presence of an alkylator,
the CXXC-thiol will be modified before it attacks the intersubunit
disulfide. As a consequence, isomerization will be blocked,
further activation will be arrested, and Env will accumulate
as an intermediate (
21). Therefore, the mutant and wt viruses
were bound by centrifugation to the receptor-positive XC cells
on ice and then incubated at 37°C in Dulbecco's phosphate-buffered
saline (pH 7.5) for 30 min in the presence of a membrane-impermeable
alkylator, M135 (2 mM; Toronto Research Chemicals). After this
process, the alkylator was washed off, the virus-cell samples
were lysed in the absence of an alkylator, and the viral proteins
were immunocaptured for analyses of alkylated, covalently linked
SU-TM complexes and free subunits by SDS-PAGE at nonreducing
conditions. Because lysis in the absence of an alkylator will
induce isomerization in all Env's that have not already undergone
receptor-mediated triggering and subsequent alkylation, the
amount of covalently linked SU-TM complexes will correspond
to the amount of receptor-triggered Env. As controls, we used
cell-bound viruses that were kept on ice with M135 for 30 min
before being washed and lysed. The control samples showed only
free SU and TM, i.e., Pr15E and p15E, but no SU-TM complexes
(Fig.
3A, lanes 1, 3, 5, 7, and 9). This indicated that no Env's
had been induced by the receptor and subsequently isomerization
blocked by the alkylator at these conditions. However, isomerization-resistant
SU-TM complexes, i.e., alkylated Env intermediates, appeared
in the samples that had been incubated at 37°C in the presence
of an alkylator (Fig.
3A, lanes 2, 4, 6, 8, and 10). Notably,
the amounts of intermediates were very much reduced in the cleavage-inhibited
mutants L649R and L649I and significantly reduced in the less-cleavage-inhibited
mutant L649V compared to those of the wt and the cleavage-competent
mutant V650I. This finding was confirmed by quantification of
the fraction of TM subunits present in alkylated SU-TM complexes
(Fig.
3B). To get an estimate of how efficiently the Pr15E-SU
and p15E-SU complexes, respectively, were triggered and blocked
as intermediates, we measured the amounts of Pr15E and p15E
that had been released from the corresponding SU complexes by
lysis-induced isomerization (Fig.
3A, lanes 2, 4, 6, 8, and
10) and compared them to the total amounts of Pr15E and p15E
in the corresponding nonincubated samples, which had been totally
isomerized (Fig.
3A, lanes 1, 3, 5, 7, and 9). The signal levels
facilitated reliable quantifications of Pr15E release in L649V,
L649R, and L649I and of p15E release in the wt, L649V, and V650I.
We found that the lysis-releasable p15E fraction was only 50%
to 70%, in contrast to the lysis-releasable Pr15E fraction,
which was about 95% (Fig.
3C). This indicated that the SU-p15E
complexes were preferentially triggered by the receptor and
converted into the alkylated intermediate, whereas the SU-Pr15E
complexes were inhibited in this reaction. This was confirmed
by an analysis of the alkylated samples with the R-peptide pAb,
which reacted only with the R-peptide-containing, lysis-released
Pr15E and alkylated Pr15E-SU intermediates (Fig.
3D). Quantification
showed that only about 5% to 6% of the Pr15E-SU complexes of
the mutants was triggered by the receptor to form the alkylated
intermediate.
Altogether, we demonstrated that the R peptide suppressed the
fusion-controlling SU-TM disulfide isomerase contained within
the CXXC-motif of the SU subunit. The R peptide might interfere
with the activation of the isomerization-active CXXC-thiol or
any preceding step of Env activation, including receptor binding.
However, the fact that suppression was also observed in the
receptor-bypassing in vitro reaction using Ca
2+ depletion suggests
that another early step or steps are involved. Earlier, it was
found that cell-associated Env with the R peptide is unable
to support the membrane stalk and pore formation required for
membrane fusion, suggesting that the step(s) before TM hairpin
completion are affected (
12). Several studies have suggested
that the R peptide stabilizes the structure of the native Env
oligomer, e.g., by participating in coiled-coil formation of
the TM cytoplasmic tail or interacting with a cellular factor
and that cleavage potentiates activation through its destabilization.
Thus, structural differences have been observed in the ectodomain
of Env with and without the R peptide (
1). Mutations of residues
predicted to support R-peptide coiled-coil formation have been
shown to rescue fusion of R-peptide-containing Env (
11,
18,
23). Finally, the R peptide has been shown to suppress the activation
of other viral fusion proteins when fused to their cytoplasmic
tails (
10,
22). Our present results are also consistent with
the stabilization model.

ACKNOWLEDGMENTS
We thank R. Nordström for advice throughout this work and
K. B. Andersen for the R-peptide antibody.
Swedish Science Foundation grant 2778 and Swedish Cancer Foundation grant 0525 to H.G. supported this work.

FOOTNOTES
* Corresponding author. Mailing address: Department of Biosciences and Nutrition, Karolinska Institute, S-141 57 Huddinge, Sweden. Phone: 46-8-6089125. Fax: 46-8-7745538. E-mail:
henrik.garoff{at}cbt.ki.se 
Published ahead of print on 19 December 2007. 

REFERENCES
1 - Aguilar, H. C., W. F. Anderson, and P. M. Cannon. 2003. Cytoplasmic tail of Moloney murine leukemia virus envelope protein influences the conformation of the extracellular domain: implications for mechanism of action of the R peptide. J. Virol. 77:1281-1291.[CrossRef][Medline]
2 - Bobkova, M., J. Stitz, M. Engelstadter, K. Cichutek, and C. J. Buchholz. 2002. Identification of R-peptides in envelope proteins of C-type retroviruses. J. Gen. Virol. 83:2241-2246.[Abstract/Free Full Text]
3 - Brody, B. A., S. S. Rhee, and E. Hunter. 1994. Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J. Virol. 68:4620-4627.[Abstract/Free Full Text]
4 - Colicelli, J., and S. P. Goff. 1988. Sequence and spacing requirements of a retrovirus integration site. J. Mol. Biol. 199:47-59.[CrossRef][Medline]
5 - Green, N., T. M. Shinnick, O. Witte, A. Ponticelli, J. G. Sutcliffe, and R. A. Lerner. 1981. Sequence-specific antibodies show that maturation of Moloney leukemia virus envelope polyprotein involves removal of a COOH-terminal peptide. Proc. Natl. Acad. Sci. USA 78:6023-6027.[Abstract/Free Full Text]
6 - Henderson, L. E., R. Sowder, T. D. Copeland, G. Smythers, and S. Oroszlan. 1984. Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag and env cleavage products. J. Virol. 52:492-500.[Abstract/Free Full Text]
7 - Januszeski, M. M., P. M. Cannon, D. Chen, Y. Rozenberg, and W. F. Anderson. 1997. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 71:3613-3619.[Abstract]
8 - Kubo, Y., and H. Amanuma. 2003. Mutational analysis of the R peptide cleavage site of Moloney murine leukaemia virus envelope protein. J. Gen. Virol. 84:2253-2257.[Abstract/Free Full Text]
9 - Li, K., S. Zhang, M. Kronqvist, M. Ekström, M. Wallin, and H. Garoff. 2007. The conserved His8 of the Moloney murine leukemia virus Env SU subunit directs the activity of the SU-TM disulphide bond isomerase. Virology 361:149-160.[CrossRef][Medline]
10 - Li, M., Z. N. Li, Q. Yao, C. Yang, D. A. Steinhauer, and R. W. Compans. 2006. Murine leukemia virus R peptide inhibits influenza virus hemagglutinin-induced membrane fusion. J. Virol. 80:6106-6114.[Abstract/Free Full Text]
11 - Li, M., C. Yang, and R. W. Compans. 2001. Mutations in the cytoplasmic tail of murine leukemia virus envelope protein suppress fusion inhibition by R peptide. J. Virol. 75:2337-2344.[Abstract/Free Full Text]
12 - Melikyan, G. B., R. M. Markosyan, S. A. Brener, Y. Rozenberg, and F. S. Cohen. 2000. Role of the cytoplasmic tail of ecotropic Moloney murine leukemia virus Env protein in fusion pore formation. J. Virol. 74:447-455.[Abstract/Free Full Text]
13 - Opstelten, D.-J., M. Wallin, and H. Garoff. 1998. Moloney murine leukemia virus envelope protein subunits, gp70 and Pr15E, form a stable disulfide-linked complex. J. Virol. 72:6537-6545.[Abstract/Free Full Text]
14 - Pinter, A., R. Kopelman, Z. Li, S. C. Kayman, and D. A. Sanders. 1997. Localization of the labile disulfide bond between SU and TM of the murine leukemia virus envelope protein complex to a highly conserved CWLC motif in SU that resembles the active-site sequence of thiol-disulfide exchange enzymes. J. Virol. 71:8073-8077.[Abstract]
15 - Ragheb, J. A., and W. F. Anderson. 1994. pH-independent murine leukemia virus ecotropic envelope-mediated cell fusion: implications for the role of the R peptide and p12E TM in viral entry. J. Virol. 68:3220-3231.[Abstract/Free Full Text]
16 - Rein, A., J. Mirro, J. G. Haynes, S. M. Ernst, and K. Nagashima. 1994. Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68:1773-1781.[Abstract/Free Full Text]
17 - Schultz, A., and A. Rein. 1985. Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology 145:335-339.[CrossRef][Medline]
18 - Taylor, G. M., and D. A. Sanders. 2003. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain. Virology 312:295-305.[CrossRef][Medline]
19 - Wallin, M., M. Ekstrom, and H. Garoff. 2004. Isomerization of the intersubunit disulphide-bond in Env controls retrovirus fusion. EMBO J. 23:54-65.[CrossRef][Medline]
20 - Wallin, M., M. Ekström, and H. Garoff. 2006. Receptor-triggered but alkylation-arrested Env of murine leukemia virus reveals the transmembrane subunit in a prehairpin conformation. J. Virol. 80:9921-9925.[Abstract/Free Full Text]
21 - Wallin, M., R. Löving, M. Ekström, K. Li, and H. Garoff. 2005. Kinetic analyses of the surface-transmembrane disulfide bond isomerization-controlled fusion activation pathway in Moloney murine leukemia virus. J. Virol. 79:13856-13864.[Abstract/Free Full Text]
22 - Yang, C., and R. W. Compans. 1996. Analysis of the cell fusion activities of chimeric simian immunodeficiency virus-murine leukemia virus envelope proteins: inhibitory effects of the R peptide. J. Virol. 70:248-254.[Abstract]
23 - Yang, C., and R. W. Compans. 1997. Analysis of the murine leukemia virus R peptide: delineation of the molecular determinants which are important for its fusion inhibition activity. J. Virol. 71:8490-8496.[Abstract]
Journal of Virology, March 2008, p. 2594-2597, Vol. 82, No. 5
0022-538X/08/$08.00+0 doi:10.1128/JVI.02039-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.